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Abstract 
 
Background: To study the susceptibility pattern of β-
lactam antibiotics and gentamicin in pathogenic clinical 
isolates with reference to the site of infection.  
Methods: In this descriptive study three prevalent 
clinical isolates were selected i.e., Escherichia coli, (n = 
203) Staphylococcus aureus (n = 194) and Pseudomonas 
aeruginosa (n = 106).  These were isolated from urine, pus, 
high vaginal swabs, and a miscellaneous group, comprised 
of blood and fluid. The antibiotics included in the study 
were from β-lactam group and gentamicin. 
Results: E. coli was mostly isolated from urine (n = 124), 
while S. aureus and P. aeruginosa were mostly isolated 
from pus samples. Among β-lactams the activity of 
imipenem was highly sensitive  against all isolates as only 
2.66 % of E. coli, 5.8% of S. aureus and none of P. 
aeruginosa isolates were resistant to imipenem. Highest 
resistance in these isolates was against ampicillin, where 
S. aureus was rather sensitive to this drug (44% ) as 
compared to E. coli (15% sensitivity) and P. aeruginosa 
(13%). Staphylococcus aureus isolates were more sensitive 
to amoxicillin/clavulanate (75%) as compared to E. coli 
(58%) & P. aeruginosa (41%). Pipracillin/tazobactam and 
3rd generation cephalosporins were also comparatively 
more sensitive (10-20% resistance). Staphylococcus aureus 
isolates showed 76% sensitivity against gentamicin while 
72% of P. aeruginosa isolates and 65% of E. coli isolates 
were sensitive to this drug. 
Conclusion: Regular evaluation of antibiotic 
sensitivity can assist in devising empiric therapy 
 
Introduction 
 
Intrinsic resistance to an antibiotic can best be 
described as resistance of an entire species to an 
antibiotic, based on inherent (and inherited) 
characteristics requiring no genetic alteration. This is 
usually due to the absence of a target for the action of 
a given antibiotic or the inability of a specific drug to 
reach its target. For example, mycoplasmas are always 
resistant to β-lactam antibiotics since they lack 
peptidoglycan (which the β-lactams act upon). 
Similarly, the outer membrane of gram negative cells 
can prevent an antibiotic from reaching its target. For 
example, Pseudomonas aeruginosa exhibits high 
intrinsic resistance to many antibiotics due to its drug 
efflux pumps and restricted outer membrane 
permeability. The major mechanisms of acquired 
resistance are the ability of the microorganisms to 
destroy or modify the drug, alter the drug target, 
reduce uptake or increase efflux of the drug, and 
replace the metabolic step targeted by the drug. 1 
The mechanism of β-lactam resistance is via 
the action of the β-lactamases. These enzymes catalyze 
hydrolysis of the β-lactam ring and, thereby, inactivate 
these antibiotics. There are also some bacteria that 
possess altered penicillin binding proteins that result 
in reduced penicillin binding. Several compounds, 
such as clavulanic acid, have been discovered that 
have the ability to bind irreversibly to β -lactamases 
and, thereby, inhibit their action. Combinations of 
these compounds with β-lactam drugs have been very 
successful in treatment of disease. 2  
 
Materials and Methods 
 
Samples were collected from both out patient 
Department (OPD) and hospitalized patients, at 
department of Pathology, Benazir Bhutto Hospital, 
Rawalpindi. The sensitivity pattern of clinically 
significant pathogenic bacteria, isolated from the 
samples was determined against commonly used β-
lactam antibiotics and gentamicin, by disk diffusion 
method. Five hundred and three bacterial isolates 
which included Escherichia coli (n= 203) 
Staphylococcus aureus (n= 194) and Pseudomonas 
aeruginosa (n= 106) were chosen after due 
identification. 242 isolates were from pus samples, 189 
isolates were from urine samples, and 45 were from 
Journal of Rawalpindi Medical College (JRMC); 2011;15(1):6-9 
 7 
high vaginal swabs (HVS). All other samples were low 
in number, and altogether the miscellaneous group 
comprised of samples of blood and fluid.For 
Morphological Identification colony size, shape, 
diameter and growth characteristics (abundant, thin, 
pigment production)  and gram stain were noted. 
Where required biochemical tests were performed . 
 
Results 
Resistance of E. coli isolates to β-lactam drugs and 
gentamicin: Third  generation cephalosporins were 
quite effective for E. coli isolates and the edge was 
taken by the  cefoperazone (CFP) . Pipracillin/ 
tazobactam (TZP) was also found to be quite effective 
as it showed resistance to 15.155 isolates. The most 
effective was imipenem. (Table 1) 
Resistance in S-aureus isolates to β-lactam and 
gentamicin: Staphylococcus aureus isolates showed 
resistance to imipenem (5.8%). In 3rd generation 
cephalosporin, cefoperazone was found more effective 
(Table 1;Fig 1) 
Resistance of P.aeruginosa to β-lactam antibiotics 
and gentamicin: Imipenem was found 100%  sensitive. 
Efficacy of TZP was remarkable(Table 3&4).     
 
Table 1:Susceptibility pattern of E. coli isolates to beta lactam antibiotics. 
Number of resistant organisms to antibiotics (%)    
Sample AMP AMC V CTX IMP CEC CAZ CFP TZP GEN 
Urine 
N=124 
62(91.17) 
N=68 
43(44.32) 
N=97 
70(57.85) 
N=121 
31(25.4) 
N=122 
2(2.15) 
N=93 
26(61.9) 
N=42 
26(23.21) 
N=112 
18(18.75) 
N=96 
15(15.15) 
N=99 
47(39.83) 
N=118 
Pus 
N=45 
22(73.33) 
N=30 
16(39) 
N=41 
26(59) 
N=44 
7(15.9) 
N=44 
1(3.57) 
N=28 
7(46.66) 
N=15 
7(17.5) 
N=40 
3(9.38) 
N=32 
3(9.09) 
N=33 
13(28.88) 
N=45 
H.V.S 
N=21 
9(81.81) 
N=11 
7(35) 
N=20 
10(47.62) 
N=21 
1(4.45) 
N=22 
1(4.76) 
N=21 
0 
N=5 
4(19.0) 
N=21 
2(11.11) 
N=18 
0 
N=14 
 
4(23.5) 
N=17 
Mis 
N-13 
4(80) 
N=5 
5(45.45) 
N=11 
5(41.66) 
N=12 
1(8.33) 
N=12 
0 
N=8 
0 
N=0 
3(27.27) 
N=11 
1(11.11) 
N=9 
0 
N=10 
5(38.46) 
N=13 
Total 
N=203 
97(85) 71(42) 111(56) 40(20.1) 4(2.66) 33(53.3) 40(21.73) 24(15.48) 18(11.54) 
69(35.75) 
N=193 
AMP,ampicillin; AMC,amoxicillin/clavulanate; CTX,cefotaxime; IMP imipenem ;MET,methicillin; CEC,cefaclor; 
CAZ,ceftazidime; CFP,cefoperazone; TZP,pipracillin/tazobactam and GEN, Gentamicin 
 
Table-2:Susceptibility pattern  of S. aureus isolates to beta lactam antibiotics 
Number of resistant organisms to antibiotics (%)  
  
 AMP AMC V CTX IMP MET CEC CAZ CFP TZP 
H.V.S 3(20) N=15 
1(5.8) 
N=17 
4(23.52) 
N=17 
3(18.7) 
N=16 
0(0) 
N=13 
3(50) 
N=6 
1(25) 
N=4 
2(15.38) 
N=13 
2(16.66) 
N=12 
0(0) 
N=13 
Pus 74(64.9) N=114 
35(30.43) 
N=115 
45(34.6) 
N=130 
18(14.17) 
N=127 
7(6.48) 
N=108 
7(12) 
N=58 
18(50) 
N=36 
17(15.88) 
N=107 
9(8.7) 
N=103 
12(11.53) 
N=104 
Misc 2(28.57) N=7 
2(22.22) 
N=9 
2(22.22) 
N=9 
2(22.22) 
N=9 
0(0) 
N=7 
1(50) 
N=2 
2(66.66) 
N=3 
1(12.5) 
N=8 
0(0) 
N=5 
0(0) 
N=5 
Urine 17(50) N=34 
7(21.2) 
N=33 
15(44.1) 
N=34 
5(15.62) 
N=32 
2(7.4) 
N=27 
7(46.6) 
N=15 
6(50) 
N=12 
6(23) 
N=26 
4(15.3) 
N=26 
5(20) 
N=25 
Total 96(56.47) 45(25.8) 66(35.10) 28(15.21) 9(5.8) 18(22.22) 27(49) 26(16.8) 15(10.2) 17(11.5) 
AMP,ampicillin;AMC, amoxicillin/clavulanate; V,cephradine; CTX, cephotaxime; IMP, imipenem; MET, methicillin; 
CEC,cefaclor; CAZ,ceftazidime;CFP, cefoperazone;  TZP, pipracillin/tazobactam 
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Table-3:Susceptibility  pattern of P.aeruginosa isolates to beta lactam antibiotics 
Number of resistant organisms to antibiotics (%)  
 
Sample  AMP AMC V CTX IMP CEC CAZ CFP TZP 
Urine 15(83.3) 
N=18 
13(56.5) 
N=24 
19(63.3) 
N=28 
8(26.6) 
N=29 
0 
N=26 
8(80) 
N=10 
3(11.5) 
N=26 
4(16) 
N=25 
3(11.5) 
N=26 
Pus 34(91.8) 
N=37 
35(66) 
N=53 
48(73.8) 
N=64 
18(27.69) 
N=65 
0 
N=46 
21(91.3) 
N=23 
7(12) 
N=60 
6(12.5) 
N=48 
5(10.2) 
N=49 
H.V.S 5(71.4) 
N=7 
3(42.8) 
N=7 
4(57.1) 
N=7 
0 
N=7 
0 
N=0 
0 
N=7 
0 
N=7 
0 
N=5 
0 
N=6 
Misc. 1(100) 
N=1 
1(100) 
N=1 
3(75) 
N=4 
2(50) 
N=4 
0 
N=3 
0 
N=2 
0 
N=3 
1(25) 
N=4 
0 
N=3 
Total 55(87.3) 52(59) 74(71.8) 60(43.1) 0 29(82.8) 10(10.6) 11(13.4) 8(9.52) 
AMP,ampicillin;AMC, amoxicillin/clavulanate;V,cephradine;CTX, cephotaxime; IMP,Imipenem; MET,methicillin; 
CEC,cefaclor;CAZ,ceftazidime;CFP,cefoperazone;TZP, pipracillin/tazobactam  
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Fig-1:Resistance of S.aureus to gentamicin 
 
Table-4:Resistance of P. aeruginosa to 
gentamicin 
Sample Gentamicin (% resistance) 
H.V.S (n=7) 0 
Pus (n=62) 19(30.6) 
Miscellaneous(n=4) 0 
Urine (n=33) 10(30.3) 
Total=105 30(28.57) 
 
Discussion 
 
In present study resistance to beta lactam in E. 
coli isolates showed high resistance against ampicillin, 
amoxicillin-clavulanate, cephradine, and cefaclor(40%) 
Results are consistent with prior published studies 
revealing increasing resistance to both ampicillin and 
cephradine, in  this part of world. 3 Highly sensitive 
antibiotic was found to be imipenem, to which only 
2.66% isolates gave  resistance.  
In a study done by Whenzel  during 2000 and 
2001 in four European countries, Canada and United 
States, in hospitalized patients. E. coli susceptibility to 
cefotaxime was 97% or greater in each country. 
Sensitivity to ampicillin was from 39-58%. Lowest 
sensitivity was from Spain while the highest sensitivity 
was from Germany. Sensitivity to amoxicillin-
clavulanate was highest in Spain i.e 85.8%. Data from 
other countries ranged from 69.9 to 81.2%. Cefotaxime 
showed sensitivity ranging from 97.1% to 99.6%. 
Ceftazidime showed results close to cefotaxime i e, 97-
99.1%. Imipenem remained 100% sensitive in all 
countries. Piperacillin-tazobactam was sensitive to 95-
97% isolates throughout these countries. 4  
During a survey of the antimicrobial 
susceptibility of pathogens from uncomplicated 
urinary tract infections, Kahlmeter reported resistance 
from 17 countries in uncomplicated community 
acquired urinary tract infections in women less than 65 
years of age. Resistance was most common to 
ampicillin (29.8%). Resistance in E. coli to co-
amoxiclav, was 21.3%. 5  The resistance to ampicillin 
and co-amoxiclav, is lower than our study, because 
their study included only uncomplicated community 
acquired urinary tract infections. Similarly in a study 
Goldstein, reported in community acquired urinary 
tract infections in France and showed higher rates of 
susceptibility in Escherichia coli, to amoxicillin-
clavulanic acid (63.3%), cephalothin (66.8%) 
cefotaxime (99.8%), ceftazidime 99%. 6 In the present  
study the sensitivity to amoxicillin-clavulanic acid was 
56%, slightly less than Goldstein, as our study also 
included hospitalized patients. 
The present study revealed that in case of S. 
aureus isolates from pus, ampicillin and cefaclor 
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showed comparatively high resistance (56% and 50%) 
followed by Cephradine (34.6%) and then amoxycillin-
clavulanic acid and methicillin (26% and 25.8%). 
Ampicillin resistance 56 % in our study is comparable 
to Sattar. 7  There are reports from many countries, of 
isolates with reduced susceptibility to vancomycin and 
teicoplanin frequently associated with a significant 
thickening of the cell wall. 8 Methicillin resistant S. 
aureus which was not the target of our study, showed 
12% pus isolates and 46.6% uropathogens were 
resistant which is comparable to other reports. 9 
Pfaller, also reports a high incidence of MRSA (28.3%) 
among urinary tract infection isolates and this was 
lowest among isolates associated with skin and soft 
tissue infections (22.4%).10 These differences might be 
due to prolonged antibiotic treatment of severely sick 
patients, who generally have longer hospital stays, 
resulting in enhanced selection pressure. 
Conclusions 
 
1.E. coli is the most prevalent bacteria in the aetiology 
of urinary tract infections.  
2.For empiric therapy of urinary tract infections, 
Pipracillin-Tazobactam can be prescribed. 
3.Among third generation cephalosporins, 
Cefoperazone has an edge over Ceftazidime and 
Cefotaxime.  
4.S.aureus and P.aeruginosa are the prevalent 
pathogens in skin and soft tissue infections. In these 
cases Pipracillin-Tazobactam and Cefoperazone could 
be prescribed empirically. Ceftazidime has an edge 
when this infection is hospital acquired, due to the 
higher isolation of P.aeruginosa in nosocomial 
infections globally. 
5.Imipenem , with a high efficacy against these three 
most common pathogens, can be prescribed in 
problematic infections. 
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